Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.amjms.2016.08.014 http://scihub22266oqcxt.onion/10.1016/j.amjms.2016.08.014 C5384343!5384343!27865299     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Med+Sci 2016 ; 352 (5): 507-16 Nephropedia Template TP {{tp|p=27865299|t=2016. Targeting the Mammalian Target of Rapamycin in Lung Cancer |pdf=|usr=}}{{27865299}} gab.com Text Targeting the Mammalian Target of Rapamycin in Lung Cancer JO: Am J Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=27865299 #FOAvip Lung cancer is the leading cause of cancer death worldwide. Despite advances in its prevention and management, the prognosis of patients with lung cancer remains poor. Therefore, much attention is being given to factors that contribute to the development of this disease, the mechanisms that drive oncogenesis and tumor progression and the search for novel targets that could lead to the development of more effective treatments. One cellular pathway implicated in lung cancer development and progression is that of the mammalian target of rapamycin. Studies involving human tissues have linked lung cancer with abnormalities in this pathway. Furthermore, studies in vitro and in vivo using animal models of lung cancer reveal that targeting this pathway might represent an effective means of treating this disease. As a result, there is significant effort invested in the development of drugs targeting mammalian target of rapamycin and related pathways in the clinical setting. Twit Text FOAVip Targeting the Mammalian Target of Rapamycin in Lung Cancer ????Am J Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=27865299 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27865299 #FOAvip English Wikipedia <ref>{{Cite pmid|27865299}}</ref> Targeting the Mammalian Target of Rapamycin in Lung Cancer #MMPMID27865299 Vicary GW; Roman J Am J Med Sci 2016[Nov]; 352 (5): 507-16 PMID27865299show ga Lung cancer is the leading cause of cancer death worldwide. Despite advances in its prevention and management, the prognosis of patients with lung cancer remains poor. Therefore, much attention is being given to factors that contribute to the development of this disease, the mechanisms that drive oncogenesis and tumor progression and the search for novel targets that could lead to the development of more effective treatments. One cellular pathway implicated in lung cancer development and progression is that of the mammalian target of rapamycin. Studies involving human tissues have linked lung cancer with abnormalities in this pathway. Furthermore, studies in vitro and in vivo using animal models of lung cancer reveal that targeting this pathway might represent an effective means of treating this disease. As a result, there is significant effort invested in the development of drugs targeting mammalian target of rapamycin and related pathways in the clinical setting. äTargeting the Mammalian Target of Rapamycin in Lung Cancer (epmc).pdf DeepDyve Pubget Overpricing